Suchergebnisse - "Locuson, Charles W"

PubPharm (69)

1

Analgesic formulation for control of pain in dogs

enthalten in: Europäisches Patentamt | 2023

von KUKANICH STANLEY | KUKANICH KATHERINE | LOCUSON CHARLES W | +1

2

Multiple-dose pharmacokinetics and opioid effects of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs

enthalten in: American journal of veterinary research | 2021

von KuKanich, B. | KuKanich, K. | Locuson, C. | +4

3

ANALGESIC FORMULATION FOR CONTROL OF PAIN IN DOGS

enthalten in: Europäisches Patentamt | 2021

von KUKANICH STANLEY | KUKANICH KATHERINE | LOCUSON CHARLES W | +1

4

Pharmacokinetics and pharmacodynamics of a novel analgesic with a deterrent to human opioid abuse (methadone-fluconazole-naltrexone) after oral administration in dogs

enthalten in: American journal of veterinary research | 2020

von KuKanich, B. | KuKanich, K. | Rankin, D. | +2

5

The effect of fluconazole on oral methadone in dogs

enthalten in: Veterinary anaesthesia and analgesia | 2019

von KuKanich, B. | KuKanich, K. | Rankin, D. | +1

6

ANALGESIC FORMULATION FOR CONTROL OF PAIN IN DOGS

enthalten in: Europäisches Patentamt | 2019

von LOCUSON CHARLES W | KUKANICH STANLEY | KUKANICH KATHERINE | +1

7

Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes

enthalten in: Xenobiotica; the fate of foreign compounds in biological systems | 2019

von Visser, M. | Zaya, M. | Locuson, C. | +2

8

Comparison of predicted intrinsic hepatic clearance of 30 pharmaceuticals in canine and feline liver microsomes

enthalten in: Xenobiotica | 2019

von Visser, M. | Zaya, M. | Locuson, C. | +2

9

Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold

enthalten in: ACS chemical neuroscience | 2018

von Bender, A. | Cho, H. | Nance, K. | +17

10

Optimization of the choline transporter (CHT) inhibitor ML352 : Development of VU6001221, an improved in vivo tool compound

enthalten in: Bioorganic & medicinal chemistry letters | 2016

von Bertron, J. | Ennis, E. | Tarr, C. | +7

1
2
3
4
5
6
7
Nächster »
[7]